Cardan Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29,289	Closed	-$2.85M	–	278
2021 Q1	$2.85M	Buy	+29,289	New	+$2.85M	0.34%	88